Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3863-3869

  Nakagoe, T ^a   Sawai, T ^a   Tsuji, T ^a   Jibiki, M ^a   Nanashima, A ^a   Yamaguchi, H ^a   Kurosaki, N ^a   Yasutake, T ^a   Ayabe, H ^a   Tagawa, Y ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Circulating STN; Colorectal cancer; Drainage vein; Sialyl Tn antigen

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; SIALIC ACID DERIVATIVE;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034528781     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2,6-N-acetylgalactosaminyl (sialosyl-Tn) epitope
2. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer
3. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients
4. Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1) Evaluation of assay conditions and normal values
5. Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer
6. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer
7. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables
8. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables
9. CEA levels of draining venous blood and draining-peripheral CEA gradient in colorectal cancer patients: Correlation with postoperative survival
10. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer
11. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival
12. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: A multivariate analysis of 572 patients
13. The prognostic value of CEA, βHGF, AFP, CA125, CA19-9, and C-erb B-2, βHCG immunohistochemistry in advanced colorectal cancer
14. Colon and Rectum
15. Definition and explanatory notes. Large intestine
16. Current status of carcinoembryonic antigen (CEA) and CEA-S assays in the evaluation of neoplasm of the gastrointestinal traet
17. The Kolmogorov-Smirnov test for goodness of fit
18. Norlparametric estimation from incomplete observation
19. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
20. Regression models and life tables
21. Peculiarities of mucinous colorectal carcinoma
22. Cell surface carbohydrates as prognostic markers in human carcinomas
23. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis